Norbert Brau

Summary

Country: USA

Publications

  1. doi request reprint Evaluation of the hepatitis C virus-infected patient: the initial encounter
    Norbert Brau
    Division of Liver Diseases, Mount Sinai School of Medicine, New York, USA
    Clin Infect Dis 56:853-60. 2013
  2. ncbi request reprint Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study
    Norbert Brau
    Bronx Veterans Affairs VA Medical Center, Infectious Disease Section 111F, 130 West Kingsbridge Road, Bronx, NY 10468, USA
    J Hepatol 47:527-37. 2007
  3. ncbi request reprint Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon alpha-2b+ full-course vs. 16-week delayed ribavirin
    Norbert Brau
    Bronx Veterans Affairs Medical Center, Bronx, NY, USA
    Hepatology 39:989-98. 2004
  4. ncbi request reprint Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy
    Norbert Brau
    Department of Medicine, Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY 10468, USA
    J Antimicrob Chemother 56:991-5. 2005
  5. pmc Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients
    Marie Louise C Vachon
    Division of Liver Diseases, Mount Sinai School of Medicine, NY, USA
    J Hepatol 54:41-7. 2011
  6. ncbi request reprint Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area
    Norbert Brau
    Veterans Affairs Medical Center, Infectious Disease Section, Bronx, New York 10468, USA
    Am J Gastroenterol 97:2071-8. 2002
  7. ncbi request reprint Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?
    Karen H Seal
    VA Medical Center, San Francisco, CA 94121, USA
    J Clin Gastroenterol 41:199-205. 2007
  8. ncbi request reprint Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy
    Norbert Brau
    Infectious Diseases Section 111F, Bronx Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468, USA
    J Hepatol 44:47-55. 2006
  9. ncbi request reprint Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin
    Norbert Brau
    Mount Sinai School of Medicine, Bronx Veterans Affairs Medical Center, Infectious Diseases Section 111F, 130 West Kingsbridge Road, New York, NY 0468, USA
    Semin Liver Dis 25:33-51. 2005
  10. ncbi request reprint National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection
    Edmund J Bini
    VA New York Harbor Healthcare System and NYU School of Medicine, New York, NY, USA
    J Clin Gastroenterol 40:732-9. 2006

Detail Information

Publications10

  1. doi request reprint Evaluation of the hepatitis C virus-infected patient: the initial encounter
    Norbert Brau
    Division of Liver Diseases, Mount Sinai School of Medicine, New York, USA
    Clin Infect Dis 56:853-60. 2013
    ..Initial counseling on therapy emphasizes viral cure rates of currently 70%-80% as well as expected side effects. New treatments with fewer side effects and potentially higher cure rates are currently in development...
  2. ncbi request reprint Presentation and outcome of hepatocellular carcinoma in HIV-infected patients: a U.S.-Canadian multicenter study
    Norbert Brau
    Bronx Veterans Affairs VA Medical Center, Infectious Disease Section 111F, 130 West Kingsbridge Road, Bronx, NY 10468, USA
    J Hepatol 47:527-37. 2007
    ..HIV-infected patients now live longer and often have complications of liver disease, especially with hepatitis B or C virus coinfection. Limited data are available on those with hepatocellular carcinoma (HCC)...
  3. ncbi request reprint Treatment of chronic hepatitis C in HIV/HCV-coinfection with interferon alpha-2b+ full-course vs. 16-week delayed ribavirin
    Norbert Brau
    Bronx Veterans Affairs Medical Center, Bronx, NY, USA
    Hepatology 39:989-98. 2004
    ..Control of HIV infection improves rather than worsens during therapy...
  4. ncbi request reprint Chronic hepatitis C in patients with HIV/AIDS: a new challenge in antiviral therapy
    Norbert Brau
    Department of Medicine, Division of Infectious Diseases, Mount Sinai School of Medicine, New York, NY 10468, USA
    J Antimicrob Chemother 56:991-5. 2005
    ..Given the safety and efficacy of combination therapy with peginterferon plus ribavirin and the deleterious effects of chronic hepatitis C, all HIV/HCV-coinfected patients should be evaluated for therapy...
  5. pmc Insulin resistance predicts re-treatment failure in an efficacy study of peginterferon-α-2a and ribavirin in HIV/HCV co-infected patients
    Marie Louise C Vachon
    Division of Liver Diseases, Mount Sinai School of Medicine, NY, USA
    J Hepatol 54:41-7. 2011
    ....
  6. ncbi request reprint Prevalence of hepatitis C and coinfection with HIV among United States veterans in the New York City metropolitan area
    Norbert Brau
    Veterans Affairs Medical Center, Infectious Disease Section, Bronx, New York 10468, USA
    Am J Gastroenterol 97:2071-8. 2002
    ..The aims of this study were to determine the prevalence of hepatitis C virus (HCV) infection and its risk factors, as well as the prevalence of coinfection with HIV and its risk factors, among patients with confirmed HCV infection...
  7. ncbi request reprint Hepatitis C treatment candidacy and outcomes among 4318 US veterans with chronic hepatitis C virus infection: does a history of injection drug use matter?
    Karen H Seal
    VA Medical Center, San Francisco, CA 94121, USA
    J Clin Gastroenterol 41:199-205. 2007
    ..Many patients with a history of injection drug use (IDU) are excluded from hepatitis C virus (HCV) treatment. This prospective multicenter study aimed to determine the impact of IDU history on HCV treatment candidacy and outcomes...
  8. ncbi request reprint Slower fibrosis progression in HIV/HCV-coinfected patients with successful HIV suppression using antiretroviral therapy
    Norbert Brau
    Infectious Diseases Section 111F, Bronx Veterans Affairs Medical Center, 130 West Kingsbridge Road, Bronx, NY 10468, USA
    J Hepatol 44:47-55. 2006
    ..This study examined whether HIV suppression through highly active antiretroviral therapy (HAART) attenuates this accelerated fibrosis progression...
  9. ncbi request reprint Treatment of chronic hepatitis C in human immunodeficiency virus/hepatitis C virus-coinfected patients in the era of pegylated interferon and ribavirin
    Norbert Brau
    Mount Sinai School of Medicine, Bronx Veterans Affairs Medical Center, Infectious Diseases Section 111F, 130 West Kingsbridge Road, New York, NY 0468, USA
    Semin Liver Dis 25:33-51. 2005
    ..Given that pegylated interferon and ribavirin have been shown to be safe and effective for HIV/HCV coinfection as well as HCV monoinfection, all HIV/HCV-coinfected patients should be evaluated for therapy...
  10. ncbi request reprint National multicenter study of HIV testing and HIV seropositivity in patients with chronic hepatitis C virus infection
    Edmund J Bini
    VA New York Harbor Healthcare System and NYU School of Medicine, New York, NY, USA
    J Clin Gastroenterol 40:732-9. 2006
    ..Although HIV testing is recommended for persons with hepatitis C virus (HCV) infection who are at risk for HIV, little is known about HIV testing in this population...